Recommended Treatment for Bacterial Vaginosis Using Metronidazole Vaginal Gel
The recommended treatment for bacterial vaginosis using metronidazole vaginal gel is one applicator full (approximately 5 grams containing 37.5 mg of metronidazole) intravaginally once daily for 5 days, preferably at bedtime. 1
Diagnosis of Bacterial Vaginosis
Before initiating treatment, bacterial vaginosis should be diagnosed using clinical criteria, which requires three of the following:
- Homogeneous, white, non-inflammatory discharge adhering to vaginal walls
- Presence of clue cells on microscopic examination
- Vaginal fluid pH greater than 4.5
- Fishy odor of vaginal discharge before or after addition of 10% KOH (whiff test) 2
Alternatively, Gram stain can be used to determine the relative concentration of bacterial morphotypes characteristic of bacterial vaginosis 3.
Treatment Options
First-line Treatment:
Alternative Regimens:
- Metronidazole 500 mg orally twice daily for 7 days (95% cure rate) 3, 2
- Metronidazole 2 g orally in a single dose (84% cure rate) 3
- Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days 3, 2
Administration Considerations
- For once-daily dosing of metronidazole vaginal gel, administer at bedtime 1
- Studies have shown that once-daily dosing (77% cure rate) is as effective as twice-daily dosing (80% cure rate) of metronidazole vaginal gel 4
- Treatment efficacy is accompanied by a decrease in vaginal Bacteroides, Gardnerella vaginalis, and Mycoplasma hominis 5
Special Populations
Pregnant Women:
- Metronidazole is contraindicated during the first trimester of pregnancy 2
- For pregnant women after the first trimester, metronidazole 500mg orally twice daily for 7 days is recommended 2
- Clindamycin vaginal cream is preferred during the first trimester 2
Side Effects and Precautions
- Metronidazole vaginal gel has fewer systemic side effects compared to oral metronidazole 3
- Common side effects of oral metronidazole include gastrointestinal disturbances, metallic taste, and potential for peripheral neuropathy with prolonged use 2
- Patients should avoid alcohol during treatment with metronidazole and for 24 hours afterward to prevent disulfiram-like reactions 3, 2
- Intravaginal products may cause higher rates of post-treatment vulvovaginal candidiasis (30.4% with metronidazole gel vs. 12.5% with oral metronidazole) 6
Follow-up and Recurrence
- Routine follow-up is unnecessary if symptoms resolve 3, 2
- Recurrence is common (50-80% within a year), and another treatment regimen different from the initial one should be used 2
- Initial recurrence rate at 1 month is approximately 15% with metronidazole gel 5
Treatment of Sexual Partners
- Routine treatment of sex partners is not recommended 3, 2
- Clinical trials indicate that partner treatment does not affect a woman's response to therapy or likelihood of relapse/recurrence 2
Clinical Pitfalls to Avoid
Misdiagnosis: Always rule out other pathogens commonly associated with vulvovaginitis (Trichomonas vaginalis, Chlamydia trachomatis, N. gonorrhoeae, Candida albicans, and Herpes simplex virus) 1
Incomplete treatment: Ensure patients understand the importance of completing the full 5-day course, even if symptoms improve earlier
Alcohol consumption: Warn patients to avoid alcohol during treatment and for 24 hours afterward 3, 2
Weakening of barrier contraceptives: Note that oil-based vaginal products might weaken latex condoms and diaphragms 2